252 related articles for article (PubMed ID: 28600185)
1. Paclitaxel Encapsulated in Halloysite Clay Nanotubes for Intestinal and Intracellular Delivery.
Yendluri R; Lvov Y; de Villiers MM; Vinokurov V; Naumenko E; Tarasova E; Fakhrullin R
J Pharm Sci; 2017 Oct; 106(10):3131-3139. PubMed ID: 28600185
[TBL] [Abstract][Full Text] [Related]
2. Application of halloysite clay nanotubes as a pharmaceutical excipient.
Yendluri R; Otto DP; De Villiers MM; Vinokurov V; Lvov YM
Int J Pharm; 2017 Apr; 521(1-2):267-273. PubMed ID: 28235623
[TBL] [Abstract][Full Text] [Related]
3. The application of halloysite tubule nanoclay in drug delivery.
Lvov YM; DeVilliers MM; Fakhrullin RF
Expert Opin Drug Deliv; 2016 Jul; 13(7):977-86. PubMed ID: 27027933
[TBL] [Abstract][Full Text] [Related]
4. Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold.
Santos AC; Ferreira C; Veiga F; Ribeiro AJ; Panchal A; Lvov Y; Agarwal A
Adv Colloid Interface Sci; 2018 Jul; 257():58-70. PubMed ID: 29887382
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
Li W; Liu D; Zhang H; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA
Acta Biomater; 2017 Jan; 48():238-246. PubMed ID: 27815166
[TBL] [Abstract][Full Text] [Related]
6. Halloysite nanotubes in analytical sciences and in drug delivery: A review.
Fizir M; Dramou P; Dahiru NS; Ruya W; Huang T; He H
Mikrochim Acta; 2018 Jul; 185(8):389. PubMed ID: 30046919
[TBL] [Abstract][Full Text] [Related]
7. Optimization of diclofenac sodium profile from halloysite nanotubules.
Krejčová K; Deasy PB; Rabišková M
Ceska Slov Farm; 2013 Apr; 62(2):71-7. PubMed ID: 23822571
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems.
Massaro M; Colletti CG; Noto R; Riela S; Poma P; Guernelli S; Parisi F; Milioto S; Lazzara G
Int J Pharm; 2015 Jan; 478(2):476-85. PubMed ID: 25498322
[TBL] [Abstract][Full Text] [Related]
9. Composite microparticles of halloysite clay nanotubes bound by calcium carbonate.
Jin Y; Yendluri R; Chen B; Wang J; Lvov Y
J Colloid Interface Sci; 2016 Mar; 466():254-60. PubMed ID: 26745741
[TBL] [Abstract][Full Text] [Related]
10. Halloysite Clay Nanotubes for Loading and Sustained Release of Functional Compounds.
Lvov Y; Wang W; Zhang L; Fakhrullin R
Adv Mater; 2016 Feb; 28(6):1227-50. PubMed ID: 26438998
[TBL] [Abstract][Full Text] [Related]
11. Electrospun microfiber membranes embedded with drug-loaded clay nanotubes for sustained antimicrobial protection.
Xue J; Niu Y; Gong M; Shi R; Chen D; Zhang L; Lvov Y
ACS Nano; 2015 Feb; 9(2):1600-12. PubMed ID: 25584992
[TBL] [Abstract][Full Text] [Related]
12. Polymer grafted-magnetic halloysite nanotube for controlled and sustained release of cationic drug.
Fizir M; Dramou P; Zhang K; Sun C; Pham-Huy C; He H
J Colloid Interface Sci; 2017 Nov; 505():476-488. PubMed ID: 28633119
[TBL] [Abstract][Full Text] [Related]
13. Halloysite clay nanotubes for controlled release of protective agents.
Lvov YM; Shchukin DG; Möhwald H; Price RR
ACS Nano; 2008 May; 2(5):814-20. PubMed ID: 19206476
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes.
Li K; Zhang Y; Chen M; Hu Y; Jiang W; Zhou L; Li S; Xu M; Zhao Q; Wan R
Int J Nanomedicine; 2018; 13():19-30. PubMed ID: 29296083
[TBL] [Abstract][Full Text] [Related]
15. Preparation of multifunctional PEG-graft-Halloysite Nanotubes for Controlled Drug Release, Tumor Cell Targeting, and Bio-imaging.
Yamina AM; Fizir M; Itatahine A; He H; Dramou P
Colloids Surf B Biointerfaces; 2018 Oct; 170():322-329. PubMed ID: 29936385
[TBL] [Abstract][Full Text] [Related]
16. Clay nanotube encapsulation for functional biocomposites.
Lvov Y; Aerov A; Fakhrullin R
Adv Colloid Interface Sci; 2014 May; 207():189-98. PubMed ID: 24268974
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-culture.
Lai X; Agarwal M; Lvov YM; Pachpande C; Varahramyan K; Witzmann FA
J Appl Toxicol; 2013 Nov; 33(11):1316-29. PubMed ID: 23606564
[TBL] [Abstract][Full Text] [Related]
18. Investigating Halloysite Nanotubes as a Potential Platform for Oral Modified Delivery of Different BCS Class Drugs: Characterization, Optimization, and Evaluation of Drug Release Kinetics.
Husain T; Shoaib MH; Ahmed FR; Yousuf RI; Farooqi S; Siddiqui F; Imtiaz MS; Maboos M; Jabeen S
Int J Nanomedicine; 2021; 16():1725-1741. PubMed ID: 33688188
[TBL] [Abstract][Full Text] [Related]
19. Temperature-responsive and biocompatible nanocarriers based on clay nanotubes for controlled anti-cancer drug release.
Hemmatpour H; Haddadi-Asl V; Burgers TCQ; Yan F; Stuart MCA; Reker-Smit C; Vlijm R; Salvati A; Rudolf P
Nanoscale; 2023 Feb; 15(5):2402-2416. PubMed ID: 36651239
[TBL] [Abstract][Full Text] [Related]
20. Halloysite clay nanotubes for tissue engineering.
Fakhrullin RF; Lvov YM
Nanomedicine (Lond); 2016 Sep; 11(17):2243-6. PubMed ID: 27527682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
